A Phase I Study of Targeted Lung Chemotherapy in the Treatment of Metastatic Tumors
Description: 

This is a phase I, open label, non-randomized single institution study to determine the maximum tolerated dose of cisplatin delivered selectively by isolated lung infusion to patients with cancer in their lung.

Study Number: 

I 70005

Phase: 
I
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01014598

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.